Drugs / Talinolol
Trials 3
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 13 trials | ||||||
| Phase 1 | NCT01788254 | Jan 2012 → May 2015 | — | Matthias Schwab | Completed | No outcome recorded |
| Phase 1 | NCT01845194 | Dec 2009 → Oct 2013 | mitochondrial membrane transport disorder | Institute of Application-oriented Research and Clinical Trials GmbH | Completed | No outcome recorded |
| Phase 1 | NCT02514941 | Jun 2007 → Mar 2010 | morbid obesity | University Medicine Greifswald | Completed | No outcome recorded |
| Comparator or background therapy1 trial | ||||||
| Phase 1 | NCT01635608 Comparator | Apr → Jul 2011 | — | University Medicine Greifswald | Completed | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 5 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Talinolol | ClinicalTrials.gov intervention name — accepted as the source's own label NCT01635608 ↗ |
| Modality | Small molecule | — CHEMBL152067 ↗ |
| Route | Oral | “after oral administration” NCT01635608 ↗ |